Longevity

NAD+ Injections: Dosing, Cost, and What to Expect Practically

The practical shape of prescribed subcutaneous NAD+: a physician evaluation and prescription, a compounded vial from a state-licensed pharmacy, small doses a few times weekly, monthly costs typically in the low hundreds, and a short list of side effects led by injection-site stinging. The unglamorous manual, including the safety hygiene the category's 2025 recall made non-optional.

Reviewed by board-certified physicians · Published 2026-08-28 · Updated 2026-08-28 · 8 min read

Key facts

  • Injectable NAD+ requires a prescription: a physician evaluation, then dispensing by a state-licensed compounding pharmacy. It is not an FDA-approved product.
  • Common prescribed patterns use small subcutaneous doses, often 50 to 100 mg, two to three times weekly, sometimes opening with a heavier loading stretch.
  • Telehealth-channel pricing typically runs in the low hundreds of dollars monthly; IV clinics price per session at several times that.
  • The commonly reported side effects are local: brief stinging or redness at the injection site. Large or fast exposure produces the flushing and nausea associated with IV drips.
  • A 2025 Class I recall of one compounder's NAD+ injection over endotoxin contamination is the case study in why pharmacy verification matters.
  • Anything sold as injectable NAD+ without a prescription sits outside the regulated system entirely.

What does getting a legitimate prescription actually involve?

The sequence is the same one this blog describes for every prescription product: a health assessment, review by a licensed physician, a prescribing decision that can be no, and dispensing by a state-licensed compounding pharmacy with your name on the label. Because injectable NAD+ has no FDA-approved indication, everything rides on that physician judgment, and a legitimate evaluation will ask about the things covered in our evidence review, including cancer history and what you are actually hoping to change.

The checkout-only sellers and peptide storefronts skip all of it. With a sterile injectable, that is not a paperwork shortcut; it is the difference between a regulated product and a vial of unverifiable origin.

What do typical doses and schedules look like?

Prescriptions commonly land in the range of 50 to 100 mg per subcutaneous injection, taken two to three times weekly, with some protocols front-loading a heavier initial stretch before settling into maintenance. The plain status of those numbers: they are practice conventions, not outputs of dose-finding trials, because outcome-calibrated dosing research does not exist yet for this product. Your prescription's numbers govern, and changing them is the prescriber's call, not a forum's.

Injection mechanics follow the standard subcutaneous playbook: rotate sites across abdomen and thighs, fresh syringe each time, sharps container, and the drawing arithmetic covered in our vial and syringe manual, where concentration on the label converts your milligrams into units.

What does it cost through legitimate channels?

Through prescription telehealth channels, monthly pricing typically sits in the low hundreds of dollars depending on dose and schedule, self-pay, since no insurer covers a product with no approved indication. IV clinics price per session, commonly several hundred dollars each, which multiplies quickly across the series protocols they recommend; the route economics are compared in our route guide. Oral precursors, for calibration, cost a fraction of either.

Whatever the channel, the pricing test from the rest of this blog applies unchanged: every cost visible before paying, medication priced separately from any membership or fee, and no bundle you cannot decompose. At CHROMA23®, the assessment is free and every cost is shown before anything is prescribed.

3/mo CHROMA23+ Membership, medication priced separately, every cost shown first.

Start the free assessment · Explore longevity treatments

What side effects should I actually expect?

At typical subcutaneous doses, the reported list is short and local: brief stinging, occasional redness or a small bump at the site, fading within hours. The dramatic effects associated with this molecule, flushing, chest pressure, nausea, belong to large fast exposure, the IV-drip pattern, and their appearance with small subcutaneous doses is unusual enough to warrant a call to the prescriber. So does anything systemic and persistent: this is a category where humility about unknowns should run in both directions.

One planning note: because evidence for benefit is unestablished, there is no clinical basis for pushing through meaningful discomfort. If it feels bad, that datum outweighs the protocol.

How do I handle the product safely, and why the recall matters

Storage is refrigerated, in the original vial, protected from light, never frozen, with the pharmacy's beyond-use date as the hard boundary; discard anything discolored or particulate. These habits carry extra weight in this category because of its 2025 case study: a compounder's NAD+ injection drew a Class I recall, the most serious tier, over endotoxin contamination, the kind of defect invisible to the user until it is not.

The defense is unglamorous: verify the dispensing pharmacy through its state board, use products only within their dates, and treat any temperature accident or appearance change as a discard-and-call event. The pharmacy's license is doing safety work that no home practice can replicate.

Frequently asked questions

How long until I would notice anything?

There is no evidence-backed timeline to give you, because trials have not established the effects a timeline would describe. Set a defined trial window and concrete markers with the prescriber up front, and let the agreement, not open-ended hope, decide whether you continue.

Does injectable NAD+ interact with my other medications?

Formal interaction studies are sparse, which is itself a reason the medication list belongs in the evaluation. The physician's screen, plus a complete list of the supplements and peptides you already use, is the working interaction check this category has.

Can I do IV sessions and home injections with the same prescription?

No; they are different products, settings, and dose scales. If you use both patterns, each prescriber should know about the other, because total exposure is the number nobody tracks when channels do not talk.

Is the stinging on injection normal?

Brief sting at the site is the most commonly reported effect of subcutaneous NAD+ and generally fades quickly. Slower injection helps some users. Pain that is severe, spreading, or persistent is not the normal pattern and belongs on the phone with the prescriber.

About CHROMA23®

CHROMA23® is a clinical weight loss platform built on prescription protocols: injectables, oral medicine, and the protocols that come next, under one 3 membership. Every prescription decision is made by an independent, board-certified physician licensed in the patient's state, and every medication is dispensed by a state-licensed pharmacy. The assessment is free. The membership is 3. The medicine is real. The physician is real.

Sources

  1. FDA: recalls, market withdrawals and safety alerts
  2. FDA: human drug compounding (503A framework)
  3. USP <797>: sterile preparation standards
  4. Grant et al.: human intravenous NAD+ infusion pilot study (Frontiers in Aging Neuroscience, 2019)
  5. NABP: verify a state-licensed pharmacy

Keep reading

This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved. Always consult a board-certified physician about your individual situation. Figures from named clinical trials describe study populations; individual results vary and are not typical.

All articles